Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells

Clinical and Experimental Metastasis

Volumn 25, Issue 3, 2008, Pages 225-231

  Marconi, Chiara ^a   Bianchini, Francesca ^a   Mannini, Antonella ^a   Mugnai, Gabriele ^a   Ruggieri, Salvatore ^a   Calorini, Lido ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cell invasiveness; Macrophages; Matrix metalloproteinase 2 (MMP 2) and 9 (MMP 9); Murine melanoma cells; Urokinase type plasminogen activator (uPA) and uPA receptor (uPAR)

Indexed keywords

GAMMA INTERFERON; GELATINASE A; GELATINASE B; MATRIGEL; MONOCLONAL ANTIBODY; PROTEINASE; THIOGLYCOLIC ACID; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA B16; MOUSE; NONHUMAN; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL MOVEMENT; COCULTURE TECHNIQUES; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; FIBROBLASTS; INTERFERON TYPE II; LAMININ; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 42449100017     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9136-0     Document Type: Article

References (34)

1. Andreasen PA, Kjoller L, Christensen L et al (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
2. Mignatti P, Rifkin DB (2000) Nonenzimatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv Cancer Res 78:103-157
3. Del Rosso M, Fibbi G, Pucci M et al (2002) Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 193:193-207
4. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174
5. Sidenius N, Blasi F (2003) The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22:205-222
6. De Vries TJ, Quax PH, Denijn M et al (1994) Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70-81
7. Hofmann UB, Westphal JR, Van Muijen GN et al (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337-344
8. Hofmann UB, Westphal JR, Waas ET et al (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81:774-782
9. D'Alessio S, Margheri F, Pucci M et al (2004) Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. Int J Cancer 110:125-133
10. Itoh T, Tanioka M, Matsuda H et al (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177-181
11. Bjorklund M, Heikkila P, Koivunen E (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279:29589-29597
12. Liotta LA, Khon EC (2001) The microenvironment of the tumor-host interface. Nature 411:375-379
13. Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498-505
14. Fidler IF, Schroit AJ (1998) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 948:151-173
15. Cecconi O, Calorini L, Mannini A et al (1997) Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages. Clin Exp Metastasis 15:94-101
16. Calorini L, Mannini A, Bianchini F et al (1999) Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. Clin Exp Metastasis 17:889-895
17. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78
18. Sica A, Schioppa T, Mantovani A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717-727
19. Lin EY, Nguyena AV, Russellb RG et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
20. Fallani A, Calorini L, Mannini A et al (2006) Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. Prostaglandins Other Lipid Mediat 81:171-177
21. Gattoni-Celli S, Calorini L, Simile MM et al (1993) Modulation by MHC class I antigens of the biology of melanoma cells. Non immunological mechanism. Melanoma Res 3:285-289
22. Chen TR (1997) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104:255-262
23. Bianchini F, D'Alessio S, Fibbi G et al (2006) Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. Oncol Rep 15:709-714
24. Thompson JE, Cubbon RM, Cummings RT et al (2002) Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 12:1219-1223
25. Jaleel M, Shenoy AR, Visweswariah SS (2004) Tyrphostins are inhibitors of guanylyl and adenylyl cyclases. Biochemistry 43:8247-8255
26. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35
27. Kim J, Yu W, Kovalski K et al (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353-362
28. Lakka SS, Gondi CS, Dinh DH et al (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 280:21882-21892
29. Harvey SR, Hurd TC, Markus G et al (2003) Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 9:4935-4943
30. Saito K, Takeha S, Shiba K et al (2000) Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis. Int J Cancer 86:24-29
31. Denkert C, Kobel M, Berger S et al (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303-308
32. Itoh T, Tanioka M, Matsuda H et al (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177-181
33. Huang S, Van Arsdall M, Tedjarati S et al (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134-1142
34. Hiratsuka S, Nakamura K, Iwai S et al (2002) MMP-9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289-300